T(3;4)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

被引:255
作者
Streubel, B
Vinatzer, U
Lamprecht, A
Raderer, M
Chott, A
机构
[1] Med Univ Vienna, Vienna Gen Hosp, Dept Pathol, Vienna, Austria
[2] Med Univ Vienna, Vienna Gen Hosp, Dept Obstet & Gynecol, Vienna, Austria
[3] Med Univ Vienna, Vienna Gen Hosp, Dept Internal Med 1, Div Oncol, Vienna, Austria
关键词
MALT lymphoma; genetics; FOXP1; MALT1; BCL10;
D O I
10.1038/sj.leu.2403644
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The three chromosomal translocations t(11; 18)( q21; q21), t( 14; 18)(q32; q21), and t( 1; 14)( p22; q32) are associated with MALT lymphoma. In a case of MALT lymphoma of the thyroid, we observed t( 3; 14)( p14.1; q32) by cytogenetic analysis. Fluorescence in situ hybridization studies showed that the immunoglobulin heavy chain locus (IGH) was rearranged on chromosome 14. Long-distance inverse polymerase chain reaction identified FOXP1 as the partner gene on chromosome 3. To determine the frequency of the t( 3; 14)( p14.1; q32), two fluorescence in situ hybridization assays were established to screen 91 MALT lymphomas, all of which were negative for the above-mentioned three translocations, and eight splenic and six nodal marginal zone lymphomas. Overall, nine MALT lymphomas (10%) harbored t( 3; 14)( p14.1; q32) comprising tumors of the thyroid ( three of six), ocular adnexa ( four of 20), and skin ( two of 20), whereas those of the stomach (n = 20), salivary gland ( n = 20), and lung ( n = 5) were negative as well as the splenic and nodal marginal zone lymphomas. Most t( 3; 14)( p14.1; q32) +MALT lymphomas harbored additional genetic abnormalities, such as trisomy 3. Further studies revealed that the three known translocations and t( 3; 14)( p14.1; q32) are mutually exclusive. Real-time quantitative reverse transcriptase polymerase chain reaction showed upregulation of FOXP1 in cases with t( 3; 14)( p14.1; q32) or trisomy 3. This study identifies FOXP1 as a new translocation partner of IGH in a site-dependent subset of MALT lymphomas.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 51 条
[1]   A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue [J].
Akagi, T ;
Motegi, M ;
Tamura, A ;
Suzuki, R ;
Hosokawa, Y ;
Suzuki, H ;
Ota, H ;
Nakamura, S ;
Morishima, Y ;
Taniwaki, M ;
Seto, M .
ONCOGENE, 1999, 18 (42) :5785-5794
[2]  
[Anonymous], Database of chromosome aberrations and gene fusions in cancer
[3]   t(11;18)(q21;q21) is the most common translocation in MALT lymphomas [J].
Auer, IA ;
Gascoyne, RD ;
Connors, JM ;
Cotter, FE ;
Greiner, TC ;
Sanger, WG ;
Horsman, DE .
ANNALS OF ONCOLOGY, 1997, 8 (10) :979-985
[4]  
Banham AH, 2001, CANCER RES, V61, P8820
[5]   Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome [J].
Barrans, SL ;
Fenton, JAL ;
Banham, A ;
Owen, RG ;
Jack, AS .
BLOOD, 2004, 104 (09) :2933-2935
[6]   Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) [J].
Borkhardt, A ;
Repp, R ;
Haas, OA ;
Leis, T ;
Harbott, J ;
Kreuder, J ;
Hammermann, J ;
Henn, T ;
Lampert, F .
ONCOGENE, 1997, 14 (02) :195-202
[7]   Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma [J].
Cerroni, L ;
Zochling, N ;
Putz, B ;
Kerl, H .
JOURNAL OF CUTANEOUS PATHOLOGY, 1997, 24 (08) :457-461
[8]  
DAVIS RJ, 1994, CANCER RES, V54, P2869
[9]   The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas [J].
Dierlamm, J ;
Baens, M ;
Wlodarska, I ;
Stefanova-Ouzounova, M ;
Hernandez, JM ;
Hossfeld, DK ;
De Wolf-Peeters, C ;
Hagemeijer, A ;
Van den Berghe, H ;
Marynen, P .
BLOOD, 1999, 93 (11) :3601-3609
[10]   Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas [J].
Ferreri, AJM ;
Guidoboni, M ;
Ponzoni, M ;
De Conciliis, C ;
Dell'Oro, S ;
Fleischhauer, K ;
Caggiari, L ;
Lettini, AA ;
Dal Cin, E ;
Ieri, R ;
Freschi, M ;
Villa, E ;
Boiocchi, M ;
Dolcetti, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (08) :586-594